AI Screening Is Not Diagnosis — Why the Difference Matters
Clinical AI screening tools like GIA® identify early risk signals and deliver them to clinicians for review. Screening is not diagnosis — and understanding the difference is essential for safe, effective use of AI in clinical settings.
What Screening Is
Screening is the systematic process of identifying patients who may be at risk for a condition — before symptoms are obvious or a formal diagnosis has been made. Screening tools analyze signals and flag potential risk. They do not confirm the presence of a condition.
What Diagnosis Is
Diagnosis is a clinical determination made by a qualified healthcare professional. It requires clinical judgment, comprehensive evaluation, and often additional testing. Diagnosis cannot be made by an AI screening tool alone.
Key Differences
| Screening | Diagnosis | |
|---|---|---|
| Purpose | Identify risk signals | Confirm condition |
| Who performs it | AI system + clinician review | Clinician |
| Output | Risk indicators | Clinical determination |
| Action required | Clinician review | Treatment plan |
| GIA® role | Yes — screening only | No |
How GIA® Fits Into This
GIA® is a clinical screening system. It analyzes speech and visual signals during a short patient interaction and identifies early indicators of cognitive, neurological, and behavioral risk. GIA® delivers those results into the clinician’s EHR workflow for review.
GIA® screens. It does not diagnose. Every result is reviewed by a clinician before it enters the clinical record. No clinical action is taken without clinician approval.
The Clinical Workflow
- GIA® conducts a short screening interaction with the patient
- GIA® analyzes risk signals and generates a structured result
- Result is delivered to the clinician’s EHR in under 2 minutes
- Clinician reviews the result and applies clinical judgment
- Clinician approves before the result enters the clinical record
- No diagnosis is made by GIA® at any point
Why This Matters for Physicians
- Screening supports clinical judgment — it does not replace it
- Physicians remain the decision-maker at every step
- AI screening reduces the time required to identify at-risk patients
- All flagged results require clinician interpretation before any action
Regulatory Context
GIA® is registered with the FDA as a medical device establishment. It is HIPAA compliant and designed for use within existing clinical workflows. GIA® does not diagnose, treat, cure, or prevent any disease or condition.
Frequently Asked Questions
What is the difference between AI screening and clinical diagnosis?
AI screening identifies early risk signals for clinician review. Clinical diagnosis is a determination made by a qualified healthcare professional based on comprehensive evaluation and clinical judgment. GIA® is a screening tool — it analyzes speech biomarkers and visual signals to surface early risk indicators. GIA® does not diagnose. Every result is reviewed by a clinician before entering the clinical record.
Can a physician rely on GIA® results without reviewing them?
No. Every GIA® result requires clinician review before it enters the clinical record. No clinical action should be taken based on GIA® results alone.
What happens after GIA® flags a risk signal?
The result appears in the clinician's EHR. The clinician reviews it, applies clinical judgment, and decides on next steps. GIA® does not recommend treatment or make diagnostic determinations.
What is GIA®'s FDA registration status?
Scienza Health is an FDA-registered medical device establishment. This means the facility producing GIA® is registered with and inspected by the FDA. GIA® screens. It does not diagnose.